X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (109339) 109339
Publication (13770) 13770
Newsletter (2050) 2050
Book Chapter (897) 897
Book Review (685) 685
Conference Proceeding (209) 209
Dissertation (180) 180
Newspaper Article (132) 132
Magazine Article (84) 84
Book / eBook (66) 66
Web Resource (36) 36
Government Document (21) 21
Reference (18) 18
Data Set (16) 16
Streaming Video (11) 11
Trade Publication Article (9) 9
Paper (3) 3
Journal / eJournal (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (79912) 79912
index medicus (44846) 44846
hematology (31215) 31215
female (30936) 30936
oncology (30889) 30889
male (30702) 30702
animals (26879) 26879
acute myeloid-leukemia (22698) 22698
adult (21775) 21775
middle aged (21189) 21189
cancer (18203) 18203
mice (18153) 18153
leukemia (16770) 16770
aged (15574) 15574
immunology (11558) 11558
adolescent (11198) 11198
research (10470) 10470
acute myeloid leukemia (10135) 10135
expression (10076) 10076
cell biology (9878) 9878
apoptosis (9388) 9388
leukemia, myeloid, acute - genetics (8913) 8913
prognosis (8699) 8699
chronic myeloid leukemia (8609) 8609
child (8203) 8203
chronic myeloid-leukemia (8155) 8155
biochemistry & molecular biology (8019) 8019
leukemia, myeloid, acute - pathology (7896) 7896
mutation (7248) 7248
chemotherapy (7243) 7243
transplantation (7235) 7235
cell line, tumor (7188) 7188
article (6932) 6932
analysis (6889) 6889
leukemia, myeloid, acute - drug therapy (6873) 6873
stem cells (6839) 6839
gene expression (6667) 6667
acute disease (6476) 6476
care and treatment (6395) 6395
acute lymphoblastic-leukemia (6379) 6379
hemic and lymphatic diseases (6192) 6192
chronic myelogenous leukemia (6095) 6095
genetic aspects (6055) 6055
treatment outcome (6002) 6002
health aspects (5835) 5835
acute myelogenous leukemia (5754) 5754
cells (5655) 5655
signal transduction (5548) 5548
cell line (5497) 5497
flow cytometry (5481) 5481
myeloid cells (5424) 5424
proteins (5403) 5403
cells, cultured (5338) 5338
aged, 80 and over (5300) 5300
child, preschool (5296) 5296
differentiation (5272) 5272
antineoplastic agents - therapeutic use (5193) 5193
bone marrow (5112) 5112
activation (5040) 5040
medicine, research & experimental (4913) 4913
mice, inbred c57bl (4894) 4894
therapy (4793) 4793
leukemia, myeloid, acute - therapy (4741) 4741
leukemia, myeloid - pathology (4714) 4714
young adult (4617) 4617
tumor cells, cultured (4605) 4605
hematopoietic stem cells (4409) 4409
genetics & heredity (4343) 4343
apoptosis - drug effects (4325) 4325
aml (4309) 4309
antineoplastic agents - pharmacology (4266) 4266
risk factors (4254) 4254
myeloid leukemia (4220) 4220
antineoplastic combined chemotherapy protocols - therapeutic use (4207) 4207
cell differentiation (4204) 4204
dendritic cells (4143) 4143
abridged index medicus (4114) 4114
pharmacology & pharmacy (4097) 4097
tumors (4043) 4043
inflammation (4035) 4035
survival (4013) 4013
hematology, oncology and palliative medicine (4004) 4004
leukemia, myeloid - genetics (4000) 4000
leukemia, myeloid, acute - metabolism (3975) 3975
infant (3831) 3831
gene (3787) 3787
myeloid-leukemia (3784) 3784
multidisciplinary sciences (3712) 3712
cell proliferation (3545) 3545
research article (3522) 3522
colony-stimulating factor (3499) 3499
retrospective studies (3493) 3493
immunotherapy (3481) 3481
gene-expression (3471) 3471
medicine & public health (3464) 3464
bone marrow - pathology (3456) 3456
genes (3441) 3441
karyotyping (3411) 3411
hematopoietic stem cell transplantation (3406) 3406
imatinib mesylate (3404) 3404
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (29) 29
Online Resources - Online (23) 23
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
UTL at Downsview - May be requested (2) 2
Credit Valley Hospital - Stacks (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Reference (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (107358) 107358
Chinese (1172) 1172
Japanese (904) 904
German (791) 791
French (714) 714
Russian (628) 628
Spanish (253) 253
Polish (206) 206
Italian (108) 108
Korean (93) 93
Portuguese (51) 51
Czech (45) 45
Hungarian (36) 36
Danish (18) 18
Dutch (18) 18
Croatian (17) 17
Turkish (17) 17
Serbian (15) 15
Swedish (12) 12
Norwegian (11) 11
Romanian (11) 11
Slovak (10) 10
Persian (9) 9
Ukrainian (7) 7
Bulgarian (6) 6
Slovenian (5) 5
Bosnian (3) 3
Finnish (3) 3
Arabic (2) 2
Afrikaans (1) 1
Greek (1) 1
Hebrew (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Investigation, ISSN 0021-9738, 05/2009, Volume 119, Issue 5, pp. 1109 - 1123
Imatinib mesylate (IM), a potent inhibitor of the BCR/ABL tyrosine kinase, has become standard first-line therapy for patients with chronic myeloid leukemia... 
CHRONIC MYELOGENOUS LEUKEMIA | MEDICINE, RESEARCH & EXPERIMENTAL | MALIGNANT GLIOMA-CELLS | BLAST CRISIS | CLINICAL RESISTANCE | BCR-ABL MUTATIONS | ENDOPLASMIC-RETICULUM | CYTOCHROME-C RELEASE | CASPASE ACTIVATION | IMATINIB RESISTANCE | CHRONIC MYELOID-LEUKEMIA | Transcription Factor CHOP - genetics | Neoplastic Stem Cells - cytology | Gene Expression - drug effects | Calcium - metabolism | Gene Expression - genetics | Microtubule-Associated Proteins - metabolism | Neoplastic Stem Cells - drug effects | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Endoplasmic Reticulum - metabolism | Antineoplastic Agents - therapeutic use | Autophagy - physiology | Thiazoles - therapeutic use | Autophagy - drug effects | Chloroquine - pharmacology | Neoplastic Stem Cells - metabolism | RNA Interference | Endoplasmic Reticulum - drug effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Macrolides - pharmacology | Antineoplastic Agents - pharmacology | Cell Death - drug effects | Dasatinib | Chloroquine - therapeutic use | Piperazines - therapeutic use | Pyrimidines - pharmacology | Imatinib Mesylate | Piperazines - pharmacology | Mice, Inbred C3H | Xenograft Model Antitumor Assays | Fusion Proteins, bcr-abl - genetics | Animals | Cell Death - physiology | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Fusion Proteins, bcr-abl - antagonists & inhibitors | Cell Line, Tumor | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Mice | Protein Kinase Inhibitors - pharmacology | Thiazoles - pharmacology | Benzamides | Macrolides - therapeutic use | Protein-Tyrosine Kinases - antagonists & inhibitors | Causes of | Physiological aspects | Genetic aspects | Chronic myeloid leukemia | Research | Drug therapy | Phagocytosis
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2017, Volume 23, Issue 3, pp. 452 - 458
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2012, Volume 7, Issue 12, p. e51845
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 03/2015, Volume 62, Issue 3, pp. 522 - 528
Journal Article
Journal Article
Transplantation, ISSN 0041-1337, 08/2016, Volume 100, Issue 8, pp. 1732 - 1739
BACKGROUNDThe impact of antithymocyte globulin (ATG) in the setting of a myeloablative conditioning transplantation remains controversial, especially when... 
SURGERY | PROGNOSTIC-FACTORS | ANTITHYMOCYTE GLOBULIN | RANDOMIZED-TRIAL | RISK | IMMUNOLOGY | VERSUS-HOST-DISEASE | TRANSPLANTATION | PROPHYLAXIS | HEMATOLOGICAL MALIGNANCIES | MYELOID-LEUKEMIA | OUTCOMES | SURVIVORS | Recurrence | Whole-Body Irradiation | Peripheral Blood Stem Cell Transplantation - methods | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Bone Marrow Transplantation - methods | Graft vs Host Disease - immunology | Transplantation Conditioning - mortality | Young Adult | Time Factors | Transplantation Conditioning - methods | Antilymphocyte Serum - adverse effects | Histocompatibility Testing | Risk Factors | HLA Antigens - immunology | Peripheral Blood Stem Cell Transplantation - mortality | Leukemia, Myeloid, Acute - mortality | Bone Marrow Transplantation - mortality | Adolescent | Myelodysplastic Syndromes - mortality | Chronic Disease | Histocompatibility | Myeloablative Agonists - therapeutic use | Multivariate Analysis | Peripheral Blood Stem Cell Transplantation - adverse effects | Leukemia, Myeloid, Acute - immunology | Cyclophosphamide - therapeutic use | Antilymphocyte Serum - therapeutic use | Adult | Dose Fractionation | Female | Leukemia, Myeloid, Acute - surgery | Transplantation Conditioning - adverse effects | Unrelated Donors | Retrospective Studies | France | Myelodysplastic Syndromes - surgery | Busulfan - therapeutic use | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Chi-Square Distribution | Disease-Free Survival | Myelodysplastic Syndromes - diagnosis | Leukemia, Myeloid, Acute - diagnosis | Graft vs Host Disease - prevention & control | Immunosuppressive Agents - adverse effects | Myelodysplastic Syndromes - immunology | Life Sciences
Journal Article
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 06/2010, Volume 207, Issue 6, pp. 1247 - 1260
Journal Article